Jung-Chool Kim
Chief Executive Officer en APROGEN BIOLOGICS INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Jung-Chool Kim is currently the Chief Executive Officer & Director at Aprogen Biologics, Inc. since 2012.
He is also a Director at Aprogen, Inc. and E&M Revolution Co., Ltd.
Additionally, he has previously worked as the Chief Executive Officer at Chunggei Pharm Co. Ltd.
and as a Director at Aprogen, Inc. and Aprogen Biologics, Inc. (Korea).
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
APROGEN, INC
0.42% | 12/04/2024 | 1 123 427 ( 0.42% ) | 1 M $ | 31/03/2024 |
APROGEN BIOLOGICS
0.00% | 28/03/2024 | 21 880 ( 0.00% ) | 3 103 $ | 31/03/2024 |
Cargos activos de Jung-Chool Kim
Empresas | Cargo | Inicio |
---|---|---|
APROGEN BIOLOGICS INC. | Chief Executive Officer | 01/04/2012 |
APROGEN MEDICINES INC. | Director/Board Member | - |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Director/Board Member | - |
Antiguos cargos conocidos de Jung-Chool Kim.
Empresas | Cargo | Fin |
---|---|---|
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | - |
Chunggei Pharm Co. Ltd. | Chief Executive Officer | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 6 |
---|---|
Aprogen, Inc. | |
Aprogen Biologics, Inc. | |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
Chunggei Pharm Co. Ltd. | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Jung-Chool Kim